MedWatch

Missionpharma expects to reach a billion within five years

Owner and chairman of the board in Missionpharma, Kim Ginnerup, wants to double company turnover over the next five years. But the largest investments are to be made outside of Denmark.

Foto: Martin Kurt Haglund, Jyllands-Posten

Growth markets, moving the company abroad and focusing on new business areas will help double turnover in the Danish pharmaceutical wholesale company Missionpharma within five years, explains chairman of the board and owner of the Danish company in an interview with Medwatch.

“In five years we will have doubled turnover, and we will be even further in our globalization process in that we will move the company to where the clients are and engage with new business areas,” says Kim Ginnerup.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier